Literature DB >> 11117267

Immune mechanisms in interstitial lung diseases.

G Semenzato1, F Adami, N Maschio, C Agostini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11117267     DOI： 10.1034/j.1398-9995.2000.00127.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  8 in total

1.  M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis.

Authors:  Stefan Prokop; Frank L Heppner; Hans H Goebel; Werner Stenzel
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

2.  A low dimensional dynamical model of the initial pulmonary innate response to infection.

Authors:  Todd R Young; Richard Buckalew; Addison K May; Erik M Boczko
Journal:  Math Biosci       Date:  2012-01-04       Impact factor: 2.144

3.  Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis.

Authors:  Kyra A Oswald-Richter; Bradley W Richmond; Nicole A Braun; Joan Isom; Susamma Abraham; Thyneice R Taylor; John M Drake; Daniel A Culver; David S Wilkes; Wonder P Drake
Journal:  J Immunol       Date:  2013-04-29       Impact factor: 5.422

4.  T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?

Authors:  M Heron; A M E Claessen; J C Grutters; J M M van den Bosch
Journal:  Clin Exp Immunol       Date:  2009-12-17       Impact factor: 4.330

5.  CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis.

Authors:  Carlo Agostini; Fiorella Calabrese; Venerino Poletti; Guido Marcer; Monica Facco; Marta Miorin; Anna Cabrelle; Ilenia Baesso; Renato Zambello; Livio Trentin; Gianpietro Semenzato
Journal:  Respir Res       Date:  2005-02-22

6.  Cytokine gene polymorphisms in Pigeon Breeder's Disease expression.

Authors:  Cláudia Freitas; Bruno Lima; Natália Martins; Natália Melo; Patrícia Mota; Hélder Novais-Bastos; Helena Alves; Oksana Sokhatska; Luís Delgado; António Morais
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-09-30       Impact factor: 0.670

7.  Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis.

Authors:  Shu-Yi Liao; Anthony N Gerber; Pearlanne Zelarney; Barry Make; Michael E Wechsler
Journal:  Chest       Date:  2022-01-10       Impact factor: 10.262

Review 8.  Immunomodulatory treatment of interstitial lung disease.

Authors:  Laura van den Bosch; Fabrizio Luppi; Giovanni Ferrara; Marco Mura
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.